NANOVIRICIDES, INC. NNVC Income Statement

Nanoviricides, inc. (NNVC)

Income statement / TTM

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10
OPERATING EXPENSES
Revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Research and development
5,346	5,992	5,921	5,910	5,891	5,873	5,913	6,676	6,944	6,565	6,565	5,799	5,307	5,199	5,028	4,888	4,367	4,131	3,660	4,475	4,554	4,768	5,131	3,944	4,677	4,257	4,292	4,259	4,482	4,784	4,265	3,924	3,994	4,097	4,155	0	0	0
Refund credit research and development costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-42	0	0	0	0	0	0
Refund credit research and development costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
2,526	2,615	2,737	2,863	3,217	3,260	3,411	2,612	2,542	2,824	3,034	4,050	3,974	3,875	3,830	4,024	3,620	3,469	3,402	3,832	3,863	3,697	3,535	2,494	2,718	2,630	2,297	2,293	1,956	1,748	1,815	1,933	2,302	2,361	2,273	0	0	0
Total operating expenses
7,873	8,608	8,659	8,773	9,109	9,133	9,325	9,289	9,486	9,390	9,600	9,849	9,282	9,074	8,859	8,913	7,987	7,601	7,063	8,307	8,418	8,465	8,667	6,438	7,395	6,888	6,590	6,552	6,438	6,532	6,081	5,815	6,296	6,458	6,429	0	0	0
LOSS FROM OPERATIONS
-7,873	-8,608	-8,659	-8,773	-9,109	-9,133	-9,325	-9,289	-9,486	-9,390	-9,600	-9,849	-9,282	-9,074	-8,859	-8,913	-7,987	-7,601	-7,063	-8,307	-8,418	-8,465	-8,667	-6,438	-7,395	-6,888	-6,590	-6,552	-6,438	-6,532	-6,081	-5,815	-6,296	-6,458	-6,429	0	0	0
OTHER INCOME (EXPENSE):
Interest income
23	38	55	73	88	98	100	0	0	0	-	-	-	67	62	78	8	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense on convertible debentures
-	-	-	0	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	85	30	31	55	35	66	71	46	67	37	21	14	0	0	0
Interest expense
0	-	-	-	0	-	-	-	-	0	-	-	-	1,042	-	1,027	2,647	2,649	2,649	2,533	3,338	3,216	3,092	3,112	1,209	1,083	962	0	0	0	-	-	-	-	-	-	-	-
Loss on issuance of Series A preferred stock for accounts payable - related party
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on extinguishment of debt
-	-	-	0	-	-	-	0	0	-	-	0	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discount on convertible debentures
-	-	-	0	-	-	359	582	880	1,183	1,347	1,504	1,570	1,496	1,427	1,361	1,295	1,235	1,175	1,010	856	707	569	548	405	264	129	0	0	0	0	0	0	0	-	-	-	-
Beneficial conversion feature of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	0	0	0	0	-	-	-	-
Non cash interest on convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Non cash interest expense on beneficial
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Non cash interest expense on beneficial conversion of convertible debentures
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Change in fair value of derivative
156	425	179	836	1,186	2,164	2,554	1,969	1,940	2,247	1,696	3,133	560	-932	541	1,149	6,522	6,999	8,529	3,434	5,751	6,000	-1,443	1,232	-4,808	-5,428	-1,249	-999	-315	-410	-172	-72	-76	-82	-62	0	0	0
Other (expense) income
33	464	235	910	1,275	734	761	-180	-1,012	142	-703	452	-1,968	-3,404	-1,865	-1,078	2,736	3,244	4,864	26	1,712	2,277	-4,934	-2,343	-6,392	-6,745	-2,285	-1,786	-249	-338	-125	-4	-38	-61	-47	0	0	0
LOSS BEFORE INCOME TAX PROVISION
-7,840	-8,144	-8,424	-7,863	-7,833	-8,399	-8,563	-9,470	-10,499	-9,248	-10,304	-9,397	-11,250	-12,479	-10,724	-9,991	-5,250	-4,356	-2,198	-8,280	-6,706	-6,188	-13,601	-8,781	-13,788	-13,633	-8,875	-8,338	-6,688	-6,871	-6,207	-5,820	-6,335	-6,519	-6,477	0	0	0
INCOME TAX PROVISION
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
NET LOSS
-7,840	-8,144	-8,424	-7,863	-7,833	-8,399	-8,563	-9,470	-10,499	-9,248	-10,304	-9,397	-11,250	-12,479	-10,724	-9,991	-5,250	-4,356	-2,198	-8,280	-6,706	-6,188	-13,601	-8,781	-13,788	-13,633	-8,875	-8,338	-6,688	-6,871	-6,207	-5,820	-6,335	-6,519	-6,477	0	0	0
NET LOSS PER COMMON SHARE
- Basic
-	-	-	-	-	-	-	-	-	-	-	61,002	58,205	58,179	57,978	57,836	57,588	57,274	57,140	56,941	56,557	55,576	-	53,318	50,031	-	-	-	-	-	-	-	-	-	-	-	-	-
- Diluted
-	-	-	-	-	-	-	-	-	-	-	61,002	58,205	58,179	57,978	57,836	57,588	57,274	62,474	59,607	59,224	55,576	-	55,033	50,031	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per common share- basic and diluted
-0.50	-0.41	1.08	-0.03	-0.64	-0.53	-0.03	-0.03	-0.04	-0.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.14	-	-0.08	-0.03	-0.04	-0.12	-0.01	-0.01	-0.01	-0.12	-0.02	-0.01	-0.01
- Basic
-	-	-	-	-	-	-	-	-	-	-	-0.05	-0.03	-0.05	-0.03	-0.09	-0.05	-0.02	-0.03	0.00	-0.03	0.02	-	0.02	-0.03	-	-	-	-	-	-	-	-	-	-	-	-	-
- Diluted
-	-	-	-	-	-	-	-	-	-	-	-0.05	-0.03	-0.05	-0.03	-0.09	-0.05	-0.02	-0.05	-0.02	-0.04	0.02	-	-0.02	-0.03	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average common shares outstanding
Weighted average common shares outstanding- basic and diluted
3,853	3,845	208,321	71,955	3,469	3,459	68,972	64,068	63,335	63,307	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	47,672	-	46,701	45,098	41,305	-272,528	151,556	147,455	144,570	-	-	-	-
Weighted average common shares outstanding: - basic and diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	140,222	138,098	135,471